Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96

  • Source: Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit Patients With Acute Myeloid Leukemia Treated With the Combination Venetoclax Plus

Record details

×
Report

XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia

  • Authors : Ehab L Atallah, Professor

  • Source: MCW-XEN21: A Phase 1 Study of XmAb18968 (CD3-CD38) for the Treatment of Patients With Relapsed/Refractory CD38 Positive Acute Leukemia and T Cell Lymphoblastic Lymphoma

Record details

×
Report

Study to Investigate the Use of Acalabrutinib in the Treatment of Patients With Chronic Lymphocytic Leukemia

  • Source: Abrqueta P, Perea A, Rozman C, Aymerh M, Ge E, Moreno C, Muntanola A, Rozman M, Vlamor N, Hodgson K, Campo E, Bosch F, Montserrat E. provg surval patnts wh chron lymphocyt leukem (1980-2008): the

Record details

×
Report

Real-World Data Study Focused on Chronic Lymphocytic Leukemia (CLL) Patient Treatment Options and Their Effectiveness (GO-CLLEAR)

  • Authors : Prof. Michael Doubek, M.D., Ph.D, Head of the Czech CLL Study Group

  • Source: A Czech Pharmaco-epidemiological Real-World Data Study Focused on CLL Patient Treatment Options and Their Effectiveness

Record details

×
Report

Relation Between Venetoclax Plasma Concentration and Remission in Adults With Acute Myeloid Leukemia (PREDICLAX)

  • Source: Study of the Association Between Residual Venetoclax Plasma Concentration and Composite Complete Remission in Adults With Newly Diagnosed Acute Myeloid Leukemia

Record details

×
Report

Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

  • Source: General Use-Results Study of Calquence Capsules 100 mg in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)

Record details

×
Report

Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia

  • Source: Andres-Jensen L, AttarbaschA, BardE, BarzaBenbo S, BhojwanD, Haglener MM, Halsey C, Hara-SaarA, van Lsenburg RRL, Hudson MM, Jeha S, Kato M, Kremer L, MlynarskW, Morke A, Pters R, Ptte C, Raetz E,

Record details

×
Report

Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

  • Source: Calquence 100 mg Capsules General Drug Use-Results Study; All Patient Investigation in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small

Record details

×
Report

Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase (TIPI)

  • Source: A Multicentre, Open-label Phase II Trial Evaluating the Safety and Efficacy of Ponatinib Induction Followed by Imatinib Maintenance in Adult Patients With Chronic Myelogenous

Record details

×
Report

International Chronic Myeloid Leukemia Pediatric Study (ICMLPed)

  • Source: INTERNATIONAL STUDY of Chronic Myeloid Leukaemia (CML) Treatment and Outcomes in Children and Adolescents

Record details

×
  • 1-10 of  12 results for ""Law""